Loading ETF research
Fetching the latest fund profile, holdings, and market data.
Fetching the latest fund profile, holdings, and market data.
New York Stock Exchange Arca · Fixed income
$21.1777
$0.00 · 0.00%
· Aug 21, 9:46 AM ET
$21.1777
Previous close$0.00 · 0.00%
· Aug 21, 9:46 AM ET
$21.38
+$1.58 · +7.98%
Historical prices · Market data may be delayed.
MHIP aims to preserve and enhancepurchasingpower amid rising medical costs through proprietary actuarial data and quantitative modeling. The fundanalysis relies on Mis extensive dataset of real healthcare claims, covering approximately 35 million insured individuals, to project healthcare inflation based on trends in medical and pharmacy costs.Investments consist ofequities and fixed income securities across the healthcare supply chain, along with inflation-hedging instruments such as commodities, TIPS, andTreasury bonds.Typically, MHIP isrebalanced monthly using a quantitative model toreflect changes in US healthcare cost inflation. The strategy increases exposure to equities and commodities during periods of higher inflation and shifts towarddebtwhen inflation is lower.Holdings may also include derivatives such as swaps, options, and futures, as well as ETFs.
Fund assets
982.35K USD
Expense ratio
0.55%
NAV
$21.35
Average volume
251
Volume
6
Day range
$20.22 – $21.1777
52-week range
$19.45 – $21.34
Previous close
$21.1777
Price change
1 day
0.00%
1 month
+5.99%
3 months
+6.58%
Year to date
+6.96%
1 year
+6.96%
3 years
+6.96%
5 years
+6.96%
Price changes exclude distributions, fees, taxes, and investor-specific cash flows.
Portfolio
Holdings data updated Aug 23, 2026.
Portfolio composition
Latest coverage
No ETF news is currently available.
More funds
Continue in GoAI
Connect this ETF with broader market context and continue your research in GoAI.
ETF data may be delayed, incomplete, or revised. Holdings and exposures change over time. Historical performance does not guarantee future results. This page is for informational and educational purposes only and does not constitute investment advice or a recommendation.
